These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3283055)

  • 1. Artificial pancreas: state of the art.
    Pfeiffer EF
    Int J Artif Organs; 1988 Jan; 11(1):13-26. PubMed ID: 3283055
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
    Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T
    Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
    Lauritzen T
    Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dawn phenomenon].
    Corcos AP; Friedmann R; Lysy Y; Chowers I
    Harefuah; 1986 Nov; 111(10):295-9. PubMed ID: 3817616
    [No Abstract]   [Full Text] [Related]  

  • 5. [Artificial endocrine pancreas].
    Mimura A; Kageyama S; Itoh K; Ikeda Y
    Nihon Rinsho; 1990 Dec; 48 Suppl():1044-51. PubMed ID: 2086866
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes.
    Mirouze J; Selam JL; Pham TC; Cavadore D
    Diabetologia; 1977 May; 13(3):273-8. PubMed ID: 873095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implantable artificial endocrine pancreas].
    Shichiri M; Nishida K; Sakakida M; Araki E
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():620-4. PubMed ID: 12387060
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of the biostator for programming the insulin infusion pump Microjet-Bolus-2 in the treatment of insulin-dependent diabetes mellitus].
    Sieradzki J; Szurkowska M
    Pol Arch Med Wewn; 1988 May; 79(5):271-7. PubMed ID: 3078197
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose monitoring and pump data management software operated on a personal digital assistant can contribute to improve diabetes control in CSII-treated patients.
    Boizel R; Benhamou PY; Renard E;
    Diabetes Metab; 2007 Sep; 33(4):314-5. PubMed ID: 17475533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term clinical application of wearable artificial endocrine pancreas].
    Konno Y; Nishida K; Shimoda S; Sakakida M; Shichiri M
    Nihon Rinsho; 1997 Nov; 55 Suppl():282-7. PubMed ID: 9434481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term clinical application of wearable artificial endocrine pancreas].
    Sakakida M; Nishida K; Shimoda S; Matsuo Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():613-9. PubMed ID: 12387059
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with optimized therapy of insulin dependent diabetes mellitus using NovoPen].
    Carta G; Borgoglio A; Borgoglio MG; Granata L; Cordera R; Adezati L
    Clin Ter; 1988 Feb; 124(4):315-20. PubMed ID: 2974343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: Artificial beta-cell in experimental and clinical medicine].
    Pfeiffer EF; Thum C; Beischer W; Clemens AH
    MMW Munch Med Wochenschr; 1975 May; 117(20):849. PubMed ID: 805997
    [No Abstract]   [Full Text] [Related]  

  • 14. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
    Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
    Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
    Rodríguez García MA; Gutiérrez López MA; Durán García S
    Med Clin (Barc); 1988 Jun; 91(3):81-2. PubMed ID: 3050312
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
    Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicomponent system for normoglycemic insulin substitution in type 1 diabetic outpatients.
    Howorka K; Stöhr H; Thoma H; Waldhäusl W
    Life Support Syst; 1985; 3 Suppl 1():540-5. PubMed ID: 3916618
    [No Abstract]   [Full Text] [Related]  

  • 18. The dawn phenomenon--fact or artefact?
    Gale EA
    Neth J Med; 1985; 28 Suppl 1():50-2. PubMed ID: 3892340
    [No Abstract]   [Full Text] [Related]  

  • 19. [Artificial endocrine pancreas].
    Kageyama S; Mimura A; Ito K; Ikeda Y
    Nihon Rinsho; 1989 Nov; 47(11):2583-8. PubMed ID: 2689692
    [No Abstract]   [Full Text] [Related]  

  • 20. [Artificial pancreas: development and significance for the study and management of diabetes].
    Pfeiffer EF; Kerner W
    Verh Dtsch Ges Inn Med; 1981; 87():1408-28. PubMed ID: 7331436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.